中外医疗
中外醫療
중외의료
China Foreign Medical Treatment
2015年
28期
66-68
,共3页
新生儿惊厥%诊断%治疗
新生兒驚厥%診斷%治療
신생인량궐%진단%치료
Neonatal seizures%Diagnosis%Treatment
目的 探究新生儿惊厥的临床诊断方法和治疗措施.方法 整群选择该院2014年2月—2015年2月收治的72例新生儿惊厥患者,分为观察组、对照组,各36例. 采用血液生化、脑电图、CT和磁共振以及头颅CT对患儿进行临床诊断;对照组给予地西沣静脉滴注,观察组给予利卡多因治疗.对比两组临床疗效、止惊时间以及神经行为评分情况. 结果 观察组治疗总有效率为83.33%(30/36),显著高于对照组的47.22%(17/36),差异有统计学意义(P<0.01). 观察组止惊时间显著短于对照组,差异有统计学意义(P<0.01). 观察组在治疗后1~7 d和10~12 d的神经行为评分显著高于对照组,差异有统计学意义(P<0.01). 结论 对于新生儿惊厥患儿采用利卡多因治疗具有显著疗效,且能够有效提高神经行为评分,值得临床推广.
目的 探究新生兒驚厥的臨床診斷方法和治療措施.方法 整群選擇該院2014年2月—2015年2月收治的72例新生兒驚厥患者,分為觀察組、對照組,各36例. 採用血液生化、腦電圖、CT和磁共振以及頭顱CT對患兒進行臨床診斷;對照組給予地西灃靜脈滴註,觀察組給予利卡多因治療.對比兩組臨床療效、止驚時間以及神經行為評分情況. 結果 觀察組治療總有效率為83.33%(30/36),顯著高于對照組的47.22%(17/36),差異有統計學意義(P<0.01). 觀察組止驚時間顯著短于對照組,差異有統計學意義(P<0.01). 觀察組在治療後1~7 d和10~12 d的神經行為評分顯著高于對照組,差異有統計學意義(P<0.01). 結論 對于新生兒驚厥患兒採用利卡多因治療具有顯著療效,且能夠有效提高神經行為評分,值得臨床推廣.
목적 탐구신생인량궐적림상진단방법화치료조시.방법 정군선택해원2014년2월—2015년2월수치적72례신생인량궐환자,분위관찰조、대조조,각36례. 채용혈액생화、뇌전도、CT화자공진이급두로CT대환인진행림상진단;대조조급여지서풍정맥적주,관찰조급여리잡다인치료.대비량조림상료효、지량시간이급신경행위평분정황. 결과 관찰조치료총유효솔위83.33%(30/36),현저고우대조조적47.22%(17/36),차이유통계학의의(P<0.01). 관찰조지량시간현저단우대조조,차이유통계학의의(P<0.01). 관찰조재치료후1~7 d화10~12 d적신경행위평분현저고우대조조,차이유통계학의의(P<0.01). 결론 대우신생인량궐환인채용리잡다인치료구유현저료효,차능구유효제고신경행위평분,치득림상추엄.
Objective To explore the clinical diagnosis and treatment of neonatal seizures. Methods 72 patients with neonatal seizures admitted to the hospital between February 2014 and February 2015 were divided into observation group and control group with 36 in each one. Blood biochemistry examination, EEG examination EEG, CT and MRI, and head CT scan were performed for the diagnosis; the control group was treated with intravenous drip of diazepam, while the observation group underwent intravenous drip of lidocaine. The clinical efficacy, the convulsion vanishing time, behavioral neurological assessment were compared between the two groups. Results The total effective rate was 83.33% (30/36) in the observation group, significantly higher than the 47.22%(17/36) in the control group, and the difference was significant (P<0.01). The convulsion vanishing time was shorter in the observa-tion group than in the control group, and the difference was statistically significant, P<0.01. The behavioral neurological assessment 1-7 day after treatment and that 10-12 d after treatment were both higher in the observation group than in the control group, and the differences were statistically significant, P<0.01. Conclusion Lidocaine can produce remarkable effect in treating neonatal seizures and can improve the behavioral neurological assessment, therefore it is worthy of promotion in clinical practice.
